BriaCell Therapeutics Corp. (BCTX)
USD 0.62
(-4.58%)
USD 0.62
(-4.58%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 82.58 Thousand | 15.52 Thousand | 15.14 Thousand | 15.57 Thousand | 13.99 Thousand | 14.27 Thousand |
| Gross Profit | -82.58 Thousand | -15.52 Thousand | -15.14 Thousand | -15.57 Thousand | -13.99 Thousand | -14.27 Thousand |
| Operating Expenses | 32.72 Million | 23.27 Million | -3388.00 | -3.68 Million | -1.38 Million | -946.42 Thousand |
| Selling, General and Administrative Expenses | 6.15 Million | 7.93 Million | 7.26 Million | -3.67 Million | -1.37 Million | -932.16 Thousand |
| Research and Development Expenses | 26.75 Million | 15.33 Million | 8.02 Million | 1.31 Million | 2.22 Million | 3.73 Million |
| Other Expenses | - | - | -15.29 Million | -1.33 Million | -2.23 Million | -3.75 Million |
| Cost and Expenses | 32.8 Million | 23.27 Million | -3388.00 | -3.68 Million | -1.38 Million | -946.42 Thousand |
| Operating Income | -32.8 Million | -23.27 Million | -15.28 Million | 3.68 Million | 1.38 Million | 946.42 Thousand |
| Interest Expense | - | - | 979.00 | 46.09 Thousand | 26.99 Thousand | 23.81 Thousand |
| Income Tax Expense | 62.85 Thousand | -152.62 Thousand | 30.73 Thousand | 6.58 Million | -72.25 Thousand | 343.74 Thousand |
| Earnings before Tax | -4.79 Million | -20.3 Million | -11.54 Million | 3.68 Million | 1.38 Million | 946.42 Thousand |
| Net Income | -4.79 Million | -20.3 Million | -11.58 Million | -2.89 Million | 1.38 Million | 602.68 Thousand |
| Earnings Per Share Basic | -0.29 | -1.30 | -0.75 | -0.64 | 1.94 | 1.04 |
| Earnings Per Share Diluted | -0.29 | -1.30 | -0.75 | -0.64 | 1.94 | 1.04 |
| Weighted Average Shares Outstanding | 16.45 Million | 15.61 Million | 15.49 Million | 4.51 Million | 713.88 Thousand | 579.66 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 16.45 Million | 15.61 Million | 15.49 Million | 4.51 Million | 713.88 Thousand | 579.66 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -4.77 Million | -30.66 Million | -15.13 Million | -8.68 Million | -3.96 Million | -6.67 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 22.67 Thousand | - | - | - | - | - |
| Cost of Revenue | 71.84 Thousand | 3759.55 | 3841.09 | 3735.04 | 3861.57 | 15.52 Thousand |
| Gross Profit | -49.17 Thousand | -3759.55 | -3841.09 | -3735.04 | -3861.57 | -15.52 Thousand |
| Operating Expenses | 5.76 Million | 9.08 Million | 9.88 Million | 8.5 Million | 7.7 Million | 23.27 Million |
| Selling, General and Administrative Expenses | 1.36 Million | 1.54 Million | 1.57 Million | 1.64 Million | 2.53 Million | - |
| Research and Development Expenses | 4.4 Million | 7.54 Million | 8.3 Million | 6.85 Million | 5.16 Million | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 5.76 Million | 9.09 Million | 9.88 Million | 8.5 Million | 7.7 Million | 23.27 Million |
| Operating Income | -5.76 Million | -9.09 Million | -9.88 Million | -8.5 Million | -7.7 Million | -23.27 Million |
| Interest Expense | - | - | - | - | -14.43 Million | - |
| Income Tax Expense | 4.44 Million | -23.16 Thousand | -39.53 Thousand | -14.5 Million | 4.82 Million | -152.62 Thousand |
| Earnings before Tax | -1.24 Million | 1.66 Million | -11.39 Million | 5.95 Million | -2.41 Million | -20.3 Million |
| Net Income | -1.21 Million | 1.71 Million | -11.35 Million | 6 Million | -2.41 Million | -20.3 Million |
| Earnings Per Share Basic | -0.07 | 0.11 | -0.71 | 0.37 | -0.15 | - |
| Earnings Per Share Diluted | -0.07 | 0.11 | -0.71 | -0.49 | -0.15 | - |
| Weighted Average Shares Outstanding | 18.02 Million | 15.98 Million | 15.98 Million | 15.98 Million | 15.98 Million | 15.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.02 Million | 15.98 Million | 15.98 Million | 16.67 Million | 15.98 Million | 15.61 Million |
| Gross Margin | -2.17 | - | - | - | - | - |
| EBIT Margin | -251.22 | - | - | - | - | - |
| Profit Margin | -53.56 | - | - | - | - | - |
| EBITDA | -5.69 Million | -9.08 Million | -9.88 Million | -22.77 Million | -7.49 Million | - |
| Earnings Before Tax Margin | -254.42 | - | - | - | - | - |
6027
STEP
ABI
JSG
002320
MRE